Louis Frisina is a thirty-five year executive and advisor to the pharmaceutical and medical device industry, serving physician practices, hedge funds and private equity firms. After graduating Summa cum laude from Dartmouth College, he received his MPA from Harvard University. Mr. Frisina has been the President of Fisher Scientific Worldwide (a NYSE company) and Worldwide Vice President of Ares Serono, a Swiss biotech company. As an entrepreneur, he has started and sold over three businesses in the medical device industry. Mr. Frisina was responsible for bringing Restylane to the US market, getting its US FDA approval and selling the North American rights to Medicis Pharmaceutical. Mr. Frisina has visited over 2,000 aesthetic medical practices and has lectured on the business and marketing of Aesthetic Medicine to societies and companies worldwide.